{"resourceType":"ImplementationGuide","id":"molitVITU","url":"http://molit.eu/fhir/vitu/ImplementationGuide/molitVITU","version":"0.1.0","name":"TrialImplementationGuide","title":"Clinical Trial Implementation Guide","status":"draft","contact":[{"name":"Molit Institute gGmbH","telecom":[{"system":"email","value":"mailto:info@molit.eu"}]}],"description":"An Implementation Guide for a FHIR based trial management","packageId":"molitVITU","license":"CC0-1.0","fhirVersion":["4.0.1"],"definition":{"resource":[{"reference":{"reference":"ValueSet/atc-vs"},"name":"ATC","description":"Includes all WHO ATC codes.","exampleBoolean":false},{"reference":{"reference":"ValueSet/biomarker-vs"},"name":"Biomarkers","description":"ValueSet for Biomarkers in VITU including EBV, HPV, HER2, PDL1, ER, PR, MSI.","exampleBoolean":false},{"reference":{"reference":"ValueSet/ecog-performance-status-vs"},"name":"ECOG","description":"ECOG Performance Status (Level 0-5).","exampleBoolean":false},{"reference":{"reference":"ValueSet/hgnc-genes-vs"},"name":"ValueSet for HGNC Genes","description":"Dieses ValueSet enthält alle HGNC GeneIDs.","exampleBoolean":false},{"reference":{"reference":"ValueSet/icd-10-gm-c-II-vs"},"name":"ICD-10-GM-Kapitel II","description":"ValueSet des Kapitel II der onkologischen ICD10-GM Primärschlüssel inklusive abgetrennter Klassentitel im Display Value.","exampleBoolean":false},{"reference":{"reference":"ValueSet/icd-10-gm-vs"},"name":"ICD-10-GM","description":"Dieses ValueSet enthält alle ICD 10 Codes der deutschen Modifikation","exampleBoolean":false},{"reference":{"reference":"ValueSet/icd-o-3-morphologie-vs"},"name":"ICD-O-3-Morphologie","description":"International Classification of Diseases for Oncology 2014 Morphology Section ValueSet.","exampleBoolean":false},{"reference":{"reference":"ValueSet/icd-o-3-topography-vs"},"name":"ICD-O-3-Topographie","description":"ValueSet aller ICD-O-3 Topographie Codes mit Überschriften im Display Value.","exampleBoolean":false},{"reference":{"reference":"ValueSet/iso3166-1-2-vs"},"name":"Iso3166-1-2","description":"This value set defines the ISO 3166 Part 1 2-letter codes","exampleBoolean":false},{"reference":{"reference":"ValueSet/LL3639-3"},"name":"PosNegNotestUnknVS","exampleBoolean":false},{"reference":{"reference":"ValueSet/LL3044-6"},"name":"PosNegUnkVS","exampleBoolean":false},{"reference":{"reference":"ValueSet/tnm-m"},"name":"TNM-M","description":"Includes the following UICC codes for TNM-M.","exampleBoolean":false},{"reference":{"reference":"ValueSet/tnm-n"},"name":"TNM-N","description":"Includes the following UICC codes for TNM-N.","exampleBoolean":false},{"reference":{"reference":"ValueSet/tnm-t"},"name":"TNM-T","description":"Includes the following UICC codes for TNM-T.","exampleBoolean":false},{"reference":{"reference":"ValueSet/tumor-type-vs"},"name":"Tumortype","description":"Dieses ValueSet enthält entitätsspezifischen Tumorsubtypen zur Verwendung in VITU.","exampleBoolean":false},{"reference":{"reference":"ValueSet/uicc-vs"},"name":"UICC-Simplified","description":"Dieses ValueSet enthält die vereinfachten UICC Codes die zur Anmeldung am ZPM benutzt werden","exampleBoolean":false},{"reference":{"reference":"ValueSet/UiccStageVS"},"name":"Simplified ValueSet for UICC Stage Codes","description":"Dieses ValueSet enthält die vereinfachten UICC Codes die zur Anmeldung am ZPM benutzt werden","exampleBoolean":false},{"reference":{"reference":"CodeSystem/AtcVituSubstanceListCS"},"name":"VITU-ATC","description":"Onkologisch relevante ATC Wirkstoffe.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/CSC"},"name":"CodeSystem Consent ZvPM","description":"This CodesySystem holds the Concepts for types of patient consent in VITU.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/clinicaltrialsrecruitmentstatus"},"name":"Clinical Trial Recruitment Status","description":"CodeSystem welches die unter https://clinicaltrials.gov/ct2/about-studies/glossary verfügbaren Recruitment Status enthält.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/CurrentState"},"name":"CurrentTumorState","description":"CodeSystem zur Beschreibung des aktuellen Stands einer Tumorerkrankung","exampleBoolean":false},{"reference":{"reference":"CodeSystem/CustomSubstancesCS"},"name":"Nicht kodierte Substanzen","description":"Substanzen, welche gegenwärtig noch keinen ATC code haben.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/DeutscheBundeslaender"},"name":"Deutsche Städte","description":"CodeSystem mit allen deutschen Bundesländern auf deutsch","exampleBoolean":false},{"reference":{"reference":"CodeSystem/GermanCities"},"name":"German Cities","description":"CodeSystem mit den englischsprachigen Repräsentationen deutscher Städte","exampleBoolean":false},{"reference":{"reference":"CodeSystem/GesamtbeurteilungTumorstatusCS"},"name":"VITU-Gesamtbeurteilung Tumorstatus (nach ADTGEKID)","description":"Codes zur Gesamtbeurteilung des Tumorstatus nach ADTGEKID.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/HGNCGeneIDCs"},"name":"HGNC GeneID CodeSystem","description":"CodeSystem of all genes and their respective HGNC Code","exampleBoolean":false},{"reference":{"reference":"CodeSystem/ICD10GM"},"name":"ICD-10-GM","description":"Deutsche Modifikation des ICD-10.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/ICD10O3"},"name":"ICD-O-3","description":"ICD-O-3 Teil des ICD-10-GM.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/MOLITOrganizations"},"name":"VITU-Organisationen","description":"Enthält die Organisationen zur Benutzung in VITU.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/NctEvidenceLevel"},"name":"DKTK-Evidence Levels","description":"Levels of Evidence developed for Molecular Tumor Boards within the German Cancer Consortium (DKTK).","exampleBoolean":false},{"reference":{"reference":"CodeSystem/TumorboardAbbruchgrund"},"name":"Tumorboard Abbruchgrund","description":"Grund des Abbruchs der Tumorboardteilnahme","exampleBoolean":false},{"reference":{"reference":"CodeSystem/UICCCS"},"name":"UICC-Klassifikation","description":"UICC-Klassifikation zum Staging einer Krebserkrankung.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/VITUNoteTypes"},"name":"VITU-Notizarten","description":"Note Types used in VITU.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/VITUWorkListStatusCS"},"name":"VITU-WorkList status","description":"CodeSystem der möglichen VITU Arbeitslistenstatus.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/VituProtocolList"},"name":"Therapieprotokollliste mit custom Kodierungen","description":"Liste onkologisch relevanter Protokolle","exampleBoolean":false},{"reference":{"reference":"ConceptMap/ClinicalTrialsToFhirResearchStudyStatus"},"name":"CT-Status-to-Fhir-ResearchStudy-Status","description":"Diese Concept Map enthält das mapping von CLinicalTrials auf FHIR Status für klinische Studien","exampleBoolean":false},{"reference":{"reference":"ConceptMap/ICD10toSubtypeCM"},"name":"ICD-10-to-NCIT-Subtype","description":"Diese Concept Map enthält die entitätsspezifische Auswahlliste der Subtypen für ICD-10 Codes","exampleBoolean":false},{"reference":{"reference":"ConceptMap/ProtocolsToAtcCM"},"name":"ProtocolsToAtcCM","exampleBoolean":false}],"page":{"nameUrl":"toc.html","title":"Table of Contents","generation":"html","page":[{"nameUrl":"index.html","title":"Home","generation":"markdown"}]},"parameter":[{"code":"copyrightyear","value":"2020+"},{"code":"releaselabel","value":"ci-build"},{"code":"apply-publisher","value":"true"},{"code":"apply-contact","value":"true"},{"code":"show-inherited-invariants","value":"false"}]}}